Low-level laser therapy improves vision in patients with age-related macular degeneration

Photomedicine and Laser Surgery

Volumn 26, Issue 3, 2008, Pages 241-245

  Ivandic, Boris T ^a   Ivandic, Tomislav ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Medical Genetic Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LASER SURGERY; LASER TISSUE INTERACTION; LASERS; POPULATION STATISTICS; PULSED LASER DEPOSITION; SEMICONDUCTOR MATERIALS;

AGE RELATED MACULAR DEGENERATION (ARMD); CONTINUOUS EMISSION; LOW LEVEL LASER THERAPY (LLLT); SEMICONDUCTOR LASER DIODES;

SEMICONDUCTOR LASERS;

ADULT; AGED; ARTICLE; CATARACT; COLOR VISION DEFECT; DIODE LASER; ELDERLY CARE; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SCOTOMA; SEMICONDUCTOR; VISION; VISUAL ACUITY;

FEMALE; HUMANS; LASER THERAPY, LOW-LEVEL; MACULAR DEGENERATION; MALE; MIDDLE AGED; VISUAL ACUITY;

EID: 46249127852     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2007.2132     Document Type: Article

References (16)

1. Pauleikhoff, D., and Holz, F.G. (1996). Age-related macular degeneration. 1. Epidemiology, pathogenesis and differential diagnosis. Ophthalmologe. 93, 299-315.
2. Apte, R.S., Scheufele, T.A., and Blomquist, P.H. (2001). Etiology of blindness in an urban community hospital setting. Ophthalmology. 108, 693-696.
3. Evans, J., and Wormald, R. (1996). Is the incidence of registrable age-related macular degeneration increasing? Br. J. Ophthalmol. 80, 9-14.
4. Moore, D.J., and Clover, G.M. (2001). The effect of age on the macromolecular permeability of human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 42, 2970-2975.
5. Liang, F.Q., and Godley, B.F. (2003). Oxidative stress-induced mitochondrial DNA damage in human pigment epithelial cells: a possible mechanism for RPE aging-related macular degeneration. Exp. Eye Res. 76, 397-403.
6. Ambati, J., Ambati, B.K., Yoo, S.H., Ianchule, S., and Adamis, A.P. (2003). Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48, 257-293.
7. Hooper, C.Y., and Guymer, R.H. (2003). New treatments in age-related macular degeneration. Clin. Experiment. Ophthalmol. 31, 376-391.
8. AREDS Report No. 8 (Age-Related Eye Disease Study Research Group). (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch. Ophthalmol. 119, 1417-1436.
9. Evans, J.R. (2002). Antioxidant vitamin and mineral supplements for age-related macular degeneration. Cochrane Database Syst. Rev. CD000254.
10. Holz, F.G., and Miller, D.W. (2003). Pharmacological therapy for age-related macular degeneration. Current developments and perspectives. Ophthalmologe. 100, 97-103.
11. Holz, F.G., and Pauleikhoff, D. (1996). Age-related macular degeneration. 2. Therapeutic approaches. Ophthalmologe. 93, 483-506.
12. Rosenfeld, P.J., Brown, D.M., Heier, J.S., Boyer, D.S., Kaiser, P.K., and Chung Kim, R.Y. (2006). Ranbizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 14, 1419-1431.
13. Desmettre, T., Maurage, C.A., and Mordon, S. (2003). Transpupillary thermotherapy (TTT) with short duration laser exposures induce heat shock protein (HSP) hyperexpression on choroidoretinal layers. Lasers Surg. Med. 33, 102-107.
14. Mester, E., Mester, A.F., and Mester, A. (1985). The biomedical effects of laser application. Lasers Surg. Med. 5, 31-39.
15. Karu, T.I. (1987). Photobiological fundamentals of low-power laser therapy. IEEE J. Quantum Electronics. 10, 1703-1717.
16. Chen, L., Yang, P., and Kijlstra, A. (2002). Distribution, markers, and functions of retinal microglia. Ocul. Immunol. Inflamm. 10, 27-39.